Does Surging Genomics Consumables Demand Reshape The Bull Case For Illumina’s Recurring Revenue Engine (ILMN)?

Recent industry reports have highlighted past and projected rapid expansion in the DNA diagnostics and genomics markets, driven by liquid biopsies, direct-to-consumer testing, and personalized ...

Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually

Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention. SAN DIEGO and MENLO ...
Nasdaq

Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand

Next-generation Sequencing-based CE-IVD Solution Provides Accurate, Reliable, Fast and Scalable End-to-end Genome-wide Noninvasive Prenatal Testing Illumina's VeriSeq NIPT Solution v2 (Photo: Business ...

$46.5 Bn Next Generation Sequencing Market Industry Trends and Global Forecasts to 2035 by Type of Component, NGS Technique, Technology, Application Area, Targ…

The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...
PharmiWeb

Genomics Market 2025-2029: Emerging Trends, Market Drivers, and Strategic Insights Revealed in New Study

The global genomics market is projected to expand by 15-17% by 2029. Key factors driving this growth include the increasing ...
Business Wire

Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand

MELBOURNE, Australia--(BUSINESS WIRE)--Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of ...